SKB264 binds TROP2, is internalized, and releases a Topo I–inhibitor payload that induces DNA damage and apoptosis. Topoisomerase I is the intracellular enzymatic payload target, not the antigen bound by the ADC, so Topo I expression alone is not directly targeted for killing.